SE430753B - Kombinerat haemophilus influenzae-bordetella pertussis-vaccin - Google Patents

Kombinerat haemophilus influenzae-bordetella pertussis-vaccin

Info

Publication number
SE430753B
SE430753B SE7811192A SE7811192A SE430753B SE 430753 B SE430753 B SE 430753B SE 7811192 A SE7811192 A SE 7811192A SE 7811192 A SE7811192 A SE 7811192A SE 430753 B SE430753 B SE 430753B
Authority
SE
Sweden
Prior art keywords
prp
bordetella pertussis
phosphate
vaccine
strain
Prior art date
Application number
SE7811192A
Other languages
English (en)
Swedish (sv)
Other versions
SE7811192L (sv
Inventor
J S-C Kuo
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SE7811192L publication Critical patent/SE7811192L/xx
Publication of SE430753B publication Critical patent/SE430753B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7811192A 1977-10-28 1978-10-27 Kombinerat haemophilus influenzae-bordetella pertussis-vaccin SE430753B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (2)

Publication Number Publication Date
SE7811192L SE7811192L (sv) 1979-04-29
SE430753B true SE430753B (sv) 1983-12-12

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7811192A SE430753B (sv) 1977-10-28 1978-10-27 Kombinerat haemophilus influenzae-bordetella pertussis-vaccin

Country Status (25)

Country Link
JP (1) JPS5480408A (xx)
AR (1) AR218932A1 (xx)
AU (1) AU520902B2 (xx)
BE (1) BE871586A (xx)
CA (1) CA1117866A (xx)
CH (1) CH649781A5 (xx)
DD (1) DD140701A5 (xx)
DE (1) DE2845745A1 (xx)
DK (1) DK154327C (xx)
ES (1) ES474611A1 (xx)
FI (1) FI63674C (xx)
FR (1) FR2407000B1 (xx)
GB (1) GB2007244B (xx)
GR (1) GR73991B (xx)
HU (1) HU178166B (xx)
IE (1) IE47474B1 (xx)
IL (1) IL55433A (xx)
IT (1) IT1107570B (xx)
NL (1) NL7810753A (xx)
NO (1) NO149611C (xx)
NZ (1) NZ188211A (xx)
PH (1) PH15882A (xx)
PL (1) PL210545A1 (xx)
SE (1) SE430753B (xx)
YU (1) YU250878A (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
IL98715A0 (en) * 1990-08-13 1992-07-15 American Cyanamid Co Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
HU9400426D0 (en) * 1991-08-16 1994-05-30 Merck & Co Inc Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
NO116869B (xx) * 1965-01-19 1969-06-02 Merck & Co Inc
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (xx) * 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
IT1107570B (it) 1985-11-25
DK154327C (da) 1989-04-03
FI783269A (fi) 1979-04-29
JPS5480408A (en) 1979-06-27
DE2845745A1 (de) 1979-05-10
IL55433A (en) 1982-09-30
CH649781A5 (de) 1985-06-14
BE871586A (fr) 1979-04-27
NZ188211A (en) 1984-09-28
NO149611B (no) 1984-02-13
DD140701A5 (de) 1980-03-26
AU520902B2 (en) 1982-03-04
NL7810753A (nl) 1979-05-02
DE2845745C2 (xx) 1987-10-01
AU4108178A (en) 1980-05-01
HU178166B (en) 1982-03-28
IL55433A0 (en) 1978-10-31
IT7851621A0 (it) 1978-10-24
IE782146L (en) 1979-04-28
DK479578A (da) 1979-04-29
FR2407000A1 (xx) 1979-05-25
PH15882A (en) 1983-04-13
JPS6231694B2 (xx) 1987-07-09
DK154327B (da) 1988-11-07
FI63674C (fi) 1983-08-10
GB2007244A (en) 1979-05-16
FI63674B (fi) 1983-04-29
NO783635L (no) 1979-05-02
YU250878A (en) 1983-12-31
SE7811192L (sv) 1979-04-29
IE47474B1 (en) 1984-03-21
CA1117866A (en) 1982-02-09
PL210545A1 (xx) 1980-02-25
AR218932A1 (es) 1980-07-15
GB2007244B (en) 1982-03-31
NO149611C (no) 1984-05-23
ES474611A1 (es) 1980-01-16
FR2407000B1 (xx) 1983-01-21
GR73991B (xx) 1984-06-06

Similar Documents

Publication Publication Date Title
US4220717A (en) Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
JP2506060B2 (ja) 赤血球及びその転換法
Frommhagen et al. The role of aggregated γ-globulins in the anticomplementary activity of human and animal sera
Springer Enzymatic and nonenzymatic alterations of erythrocyte surface antigens
US4196192A (en) Combined Haemophilus influenzae type b and pertussis vaccine
JPS61186328A (ja) 新規錯体
Holland The purification and properties of megacin, a bacteriocin from Bacillus megaterium
Barwell Some observations on the antigenic structure of psittacosis and lymphogranuloma venereum viruses. II. Treatment of virus suspensions by various reagents and the specific activity of acid extracts
JPS638340A (ja) レトロウイルスを含まぬ免疫グロブリンの製法
Kuwabara Purification and properties of tuberculin-active protein from Mycobacterium tuberculosis.
SE430753B (sv) Kombinerat haemophilus influenzae-bordetella pertussis-vaccin
JP2563797B2 (ja) ボルデテラ属細菌の蛋白質抗原の精製方法
JPS6176422A (ja) 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
US3843444A (en) Membrane separation process
WO1988008032A1 (en) Receptor from the small rhinovirus receptor group
DE3152621C2 (xx)
US3745155A (en) Purifying a gamma globulin by contacting a solution of gamma globulin with solid plasma protein free of gamma globulin
US5039610A (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
US3616211A (en) Process for producing deoxyribonucleic acid
CA1137901A (en) Isolation of capsular polysaccharide of haemophilus influenzae
KR810001317B1 (ko) 혼합백신의 제조방법
US3627874A (en) Vaccine preparation
CA1239104A (en) Method for the purification of lpf-ha
Auer et al. Studies on thermostable liver-specific antigens
Svartz Macroglobulins in Rheumatoid Arthritis and Other Diseases: Their Dissociation and Differentiation

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7811192-9

Effective date: 19920510

Format of ref document f/p: F